Skip to content

Compare your options • Marion & Belleville

Semaglutide
vs. Tirzepatide

Which weight loss option fits you?

Understand the differences, put the research in context, and prepare for a personal conversation with SI Medical. Your health history, treatment response, and goals all belong in the decision.

Discuss Your Weight Loss Options

View Current Treatment Pricing

The starting point

Compare the medicine.
Personalize the plan.

Semaglutide acts on GLP-1 receptors; tirzepatide acts on GIP and GLP-1 receptors. Compare how each option fits a personalized weight-management plan.*

The essentials, side by side

Semaglutide vs. tirzepatide
at a glance

One option to discuss

Semaglutide

GLP-1 receptor agonist

A medication option used in long-term weight-management care.*

Semaglutide injections are typically taken once weekly.*

Used alongside nutrition guidance and physical activity.

Read Semaglutide Injection Information

One option to discuss

Tirzepatide

GIP and GLP-1 receptor agonist

A medication option used in long-term weight-management care.*

Tirzepatide is typically injected once weekly.*

Used alongside nutrition guidance and physical activity.

Read Tirzepatide Injection Information

* This comparison describes injection-based weight-management treatment. Semaglutide also has oral formulations. Indications, instructions, risks, eligibility, and dose changes depend on the exact product and your evaluation. Confirm the recommended formulation with your provider; this page does not identify the product supplied by SI Medical. A consultation does not guarantee a prescription.

What the research found

A useful comparison.
A specific study.

SURMOUNT-5 was a 72-week, randomized, open-label trial involving 751 adults with obesity who did not have type 2 diabetes. It compared maximum tolerated weekly tirzepatide doses of 10 or 15 mg with semaglutide doses of 1.7 or 2.4 mg.

20.2%

Tirzepatide

Average body-weight reduction at week 72 in SURMOUNT-5.**

13.7%

Semaglutide

Average body-weight reduction at week 72 in SURMOUNT-5.**

** Tirzepatide produced greater average weight reduction under this study’s conditions. These are trial results, not SI Medical patient results or a promised outcome. The findings do not cover every formulation or dose. Lilly funded the trial; individual results vary.

Read the SURMOUNT-5 study

More than a number

The right discussion
starts with you.

Your provider brings the research together with your health conditions, medications, previous treatment experiences, and preferences to discuss a plan for you.**

Your medical history

Discuss diabetes, digestive conditions, kidney or gallbladder concerns, prior pancreatitis, and pregnancy or breastfeeding plans.

Your experience with treatment

Share what you have tried, whether it helped, and which side effects or practical difficulties affected you.

Your ability to stay supported

Consider follow-up visits, treatment costs, coverage, and the nutrition and activity habits you can maintain.

Bring your questions to a local medical weight loss appointment.

Make an informed decision

Side effects and safety matter.

Risks both options share

Nausea, vomiting, diarrhea, constipation, and abdominal discomfort can occur. Discuss persistent or severe symptoms with your provider.

Reference prescribing information for semaglutide and tirzepatide injections includes boxed warnings about thyroid C-cell tumors observed in rodents; the human risk is unknown. These products must not be used with a personal or family history of medullary thyroid carcinoma or MEN 2, or a prior serious allergy to the respective product.

Other concerns include pancreatitis, gallbladder problems, dehydration-related kidney injury, and low blood sugar with certain diabetes medicines. Tell your care team about planned anesthesia or sedation.

Differences worth discussing

Tirzepatide may reduce the effectiveness of oral hormonal contraceptives. Reference prescribing information advises a non-oral method or an added barrier method for 4 weeks after starting and 4 weeks after each dose increase.

Reference semaglutide prescribing information advises stopping at least 2 months before a planned pregnancy. Discuss pregnancy planning with your prescriber for either medicine; weight-loss treatment is not appropriate during pregnancy.

Do not combine these medicines or switch yourself. Seek urgent care for severe, persistent abdominal pain and emergency help for breathing difficulty or swelling of the face or throat.

* This is a summary, not complete safety information. Review the medication guide for your exact prescription.

Read Semaglutide Injection Information

Read Tirzepatide Injection Information

The SI Medical approach

Whichever option fits,
care stays personal.

Our family-owned clinics in Marion and Belleville place medication within a broader weight-management program. Start with a consultation and exam, discuss body composition, and work with your team on nutrition and activity.

Monthly follow-ups provide time to discuss progress, tolerability, and changes in your needs. Transition and maintenance support help you plan beyond the active weight loss phase.

Explore Our Medical Weight Loss Program

Learn More About Semaglutide

Plan for ongoing care

Compare the full cost
of your plan.

Visit our pricing page for current treatment pricing and ask which visits, testing, and medication costs your plan includes.***

*** Insurance benefits depend on your plan and prescribed product. Confirm coverage and out-of-pocket costs with the clinic and your insurer.

View Current Treatment Pricing

Your questions, answered

Know what to ask.

Use this comparison as a starting point for a conversation with your provider.

Which is better for weight loss?

Tirzepatide produced greater average weight reduction in SURMOUNT-5, under that study’s conditions. Your provider should also consider safety, tolerability, medical history, and access. There is no single choice that fits everyone.

Can I switch from semaglutide to tirzepatide?

Discuss your current product, dose, last injection, response, and side effects with your prescriber. The doses are not interchangeable. Your provider must determine whether and how to change treatment.

Can I take both together?

No. Combining tirzepatide with a GLP-1 medicine is not recommended. Bring a complete medication list to your appointment and follow your individual prescription.

Do higher doses always mean better results?

No. Dose changes depend on the exact product, prescribing instructions, treatment response, and tolerability. Do not increase your dose on your own.

Where can I find current pricing?

Use our central pricing page. Confirm the exact recommended treatment and the full cost of care with the clinic.

What should I bring to my appointment?

Bring your current medications and supplements, relevant medical history, previous weight loss experiences, and questions about goals, side effects, follow-ups, and maintenance.*

Care close to home

Two clinics. A personal conversation.

Marion, IL

1909 Coolidge Ave.
Marion, IL 62959

Call Marion: 618-997-5677
SI Medical Weight Loss Belleville Office

Belleville, IL

123 Lincoln Place Court
Belleville, IL 62221

Call Belleville: 618-234-5677

Evidence behind the comparison

Sources & further reading

Information checked November 13, 2026. Product information can change. This page is educational and does not replace individual medical advice.

SURMOUNT-5: published head-to-head study

Semaglutide: reference prescribing information

Tirzepatide: reference prescribing information

Start with your goals

Bring your questions.
Build your plan.

Talk with SI Medical about the weight-management options that may fit your health and everyday life.

Discuss Your Weight Loss Options

Medical evaluation required. Individual results vary.